세계의 카테킨 시장 규모 : 유형별, 유래별, 기능별, 용도별 - 지역 전망, 경쟁 전략, 부문 예측(-2034년)

Catechin Market Introduction and Overview

According to SPER Market Research, 'Global Catechin Market Size - By Type, By Source, By Function, By Application - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Catechin Market is predicted to reach 27.61 million by 2034 with a CAGR of 3.66%.

A naturally occurring component of plants, catechin belongs to the flavonoid family, specifically the flavan-3-ols subgroup. This type of antioxidant is well known for its health-promoting properties and is found in the highest concentration in green tea, chocolate, berries, and apples. Because they help the body combat harmful free radicals, catechins help reduce oxidative stress and inflammation. Epicatechin, epicatechin gallate, epigallocatechin, and epigallocatechin gallate (EGCG) are polyphenolic chemicals that come in a variety of stereoisomeric forms.

Restraints: There are several major challenges facing the catechins market that could hinder its growth. A major issue is the significant expense associated with extraction and processing. Production costs are increased by the high energy consumption and complex infrastructure required for advanced processes like solvent-based extraction and chromatographic purification. This pricing barrier may limit the availability of catechin products, especially in areas where consumers are price-sensitive. Regulatory complexity also presents significant challenges.

Scope of the report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Type, By Source, By Function, By Application

Regions covered North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa

Companies Covered

Biosynth, Botaniex, Caymanchem, Hangzhou Qinyuan Natural Plant Technology, Indena, INDOFINE Chemical Company, Novanat Bioresources, Taiyo, Tata Chemicals Limited, Vital-Chem.

Global Catechin Market Segmentation:

By Type: Based on the Type, Global Catechin Market is segmented as; Epicatechin, Epicatechin gallate (ECG), Epigallocatechin (EGC), Epigallocatechin gallate (EGCG), Others.

By Source: Based on the Source, Global Catechin Market is segmented as; Green tea catechins, Cocoa catechins, Grape catechins, Others.

By Function: Based on the Function, Global Catechin Market is segmented as; Antioxidants, Cardiovascular health, Weight management, Skin health, Anti-inflammatory, Brain health, Others.

By Application: Based on the Application, Global Catechin Market is segmented as; Functional foods, Functional beverages, Cosmetics and skincare, Nutraceuticals, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Table of Contents

1. Introduction

• 1.1. Scope of the report
• 1.2. Market segment analysis

2. Research Methodology

• 2.1. Research data source
  • 2.1.1. Secondary Data
  • 2.1.2. Primary Data
  • 2.1.3. SPERs internal database
  • 2.1.4. Premium insight from KOLs
• 2.2. Market size estimation
  • 2.2.1. Top-down and Bottom-up approach
• 2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

• 4.1. Driver, Restraint, Opportunity and Challenges analysis
  • 4.1.1. Drivers
  • 4.1.2. Restraints
  • 4.1.3. Opportunities
  • 4.1.4. Challenges

5. Market variable and outlook

• 5.1. SWOT Analysis
  • 5.1.1. Strengths
  • 5.1.2. Weaknesses
  • 5.1.3. Opportunities
  • 5.1.4. Threats
• 5.2. PESTEL Analysis
  • 5.2.1. Political Landscape
  • 5.2.2. Economic Landscape
  • 5.2.3. Social Landscape
  • 5.2.4. Technological Landscape
  • 5.2.5. Environmental Landscape
  • 5.2.6. Legal Landscape
• 5.3. PORTERs Five Forces
  • 5.3.1. Bargaining power of suppliers
  • 5.3.2. Bargaining power of buyers
  • 5.3.3. Threat of Substitute
  • 5.3.4. Threat of new entrant
  • 5.3.5. Competitive rivalry
• 5.4. Heat Map Analysis

6. Competitive Landscape

• 6.1. Global Catechin Market Manufacturing Base Distribution, Sales Area, Interface Type
• 6.2. Mergers & Acquisitions, Partnerships, Interface Launch, and Collaboration in Global Catechin Market

7. Global Catechin Market, By Type 2021-2034 (USD Million)

• 7.1. Epicatechin
• 7.2. Epicatechin gallate (ECG)
• 7.3. Epigallocatechin (EGC)
• 7.4. Epigallocatechin gallate (EGCG)
• 7.5. Others

8. Global Catechin Market, By Source 2021-2034 (USD Million)

• 8.1. Green tea catechins
• 8.2. Cocoa catechins
• 8.3. Grape catechins
• 8.4. Others

9. Global Catechin Market, By Function 2021-2034 (USD Million)

• 9.1. Antioxidants
• 9.2. Cardiovascular health
• 9.3. Weight management
• 9.4. Skin health
• 9.5. Anti-inflammatory
• 9.6. Brain health
• 9.7. Others

10. Global Catechin Market, By Application 2021-2034 (USD Million)

• 10.1. Functional foods
• 10.2. Functional beverages
• 10.3. Cosmetics and skincare
• 10.4. Nutraceuticals
• 10.5. Others

11. Global Catechin Market, 2021-2034 (USD Million)

• 11.1. Global Catechin Market Size and Market Share

12. Global Catechin Market, By Region, 2021-2034 (USD Million)

• 12.1. Asia-Pacific
  • 12.1.1. Australia
  • 12.1.2. China
  • 12.1.3. India
  • 12.1.4. Japan
  • 12.1.5. South Korea
  • 12.1.6. Rest of Asia-Pacific
• 12.2. Europe
  • 12.2.1. France
  • 12.2.2. Germany
  • 12.2.3. Italy
  • 12.2.4. Spain
  • 12.2.5. United Kingdom
  • 12.2.6. Rest of Europe
• 12.3. Middle East and Africa
  • 12.3.1. Kingdom of Saudi Arabia
  • 12.3.2. United Arab Emirates
  • 12.3.3. Qatar
  • 12.3.4. South Africa
  • 12.3.5. Egypt
  • 12.3.6. Morocco
  • 12.3.7. Nigeria
  • 12.3.8. Rest of Middle-East and Africa
• 12.4. North America
  • 12.4.1. Canada
  • 12.4.2. Mexico
  • 12.4.3. United States
• 12.5. Latin America
  • 12.5.1. Argentina
  • 12.5.2. Brazil
  • 12.5.3. Rest of Latin America

13. Company Profile

• 13.1. Biosynth
  • 13.1.1. Company details
  • 13.1.2. Financial outlook
  • 13.1.3. Interface summary
  • 13.1.4. Recent developments
• 13.2. Botaniex
  • 13.2.1. Company details
  • 13.2.2. Financial outlook
  • 13.2.3. Interface summary
  • 13.2.4. Recent developments
• 13.3. Caymanchem
  • 13.3.1. Company details
  • 13.3.2. Financial outlook
  • 13.3.3. Interface summary
  • 13.3.4. Recent developments
• 13.4. Hangzhou Qinyuan Natural Plant Technology
  • 13.4.1. Company details
  • 13.4.2. Financial outlook
  • 13.4.3. Interface summary
  • 13.4.4. Recent developments
• 13.5. Indena
  • 13.5.1. Company details
  • 13.5.2. Financial outlook
  • 13.5.3. Interface summary
  • 13.5.4. Recent developments
• 13.6. INDOFINE Chemical Company
  • 13.6.1. Company details
  • 13.6.2. Financial outlook
  • 13.6.3. Interface summary
  • 13.6.4. Recent developments
• 13.7. Novanat Bioresources
  • 13.7.1. Company details
  • 13.7.2. Financial outlook
  • 13.7.3. Interface summary
  • 13.7.4. Recent developments
• 13.8. Taiyo
  • 13.8.1. Company details
  • 13.8.2. Financial outlook
  • 13.8.3. Interface summary
  • 13.8.4. Recent developments
• 13.9. Tata Chemicals Limited
  • 13.9.1. Company details
  • 13.9.2. Financial outlook
  • 13.9.3. Interface summary
  • 13.9.4. Recent developments
• 13.10. Vital-Chem
  • 13.10.1. Company details
  • 13.10.2. Financial outlook
  • 13.10.3. Interface summary
  • 13.10.4. Recent developments
• 13.11. Others

14. Conclusion

15. List of Abbreviations

16. Reference Links